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ABSTRACT: Endocrine disrupting compounds are found in
increasing amounts in our environment, originating from
pesticides, plasticizers, and pharmaceuticals, among other
sources. Although the full impact of these compounds is still
under study, they have already been implicated in diseases
such as obesity, diabetes, and cancer. The list of chemicals that
disrupt normal hormone function is growing at an alarming
rate, making it crucially important to find sources of contamination and identify new compounds that display this ability.
However, there is currently no broad-spectrum, rapid test for these compounds, as they are difficult to monitor because of their
high potency and chemical dissimilarity. To address this, we have developed a new detection strategy for endocrine disrupting
compounds that is both fast and portable, and it requires no specialized skills to perform. This system is based on a native
estrogen receptor construct expressed on the surface of Escherichia coli, which enables both the detection of many detrimental
compounds and signal amplification from impedance measurements due to the binding of bacteria to a modified electrode. With
this approach, sub-ppb levels of estradiol and ppm levels of bisphenol A are detected in complex solutions. Rather than
responding to individual components, this system reports the total estrogenic activity of a sample using the most relevant
biological receptor. As an applied example, estrogenic chemicals released from a plastic baby bottle following microwave heating
were detectable with this technique. This approach should be broadly applicable to the detection of chemically diverse classes of
compounds that bind to a single receptor.
■ INTRODUCTION
Endocrine disrupting chemicals (EDCs) are increasingly
identified as potent and pervasive risks to human health.
They enter the environment through numerous human
activities, including pesticide use, agriculture, and fracking,
and they are found in consumer products such as plastic
kitchen products and food can linings.1−3 EDCs are especially
dangerous because they are harmful at very low concentrations
(picomolar to nanomolar), particularly to fetuses and new-
borns,4−8 and they are implicated in increased occurrences of
obesity, diabetes, infertility, and cancer.9−11 The rapid and
sensitive detection of these chemicals is therefore vital, ideally
using equipment that is portable and inexpensive. Unfortu-
nately, these compounds are particularly difficult to measure
because they are not defined by a common chemical structure,
but instead by their activity.12,13 To address this obstacle, we
have developed a new detection paradigm for the sensitive,
broad-spectrum detection of EDCs based on a native estrogen
receptor alpha (ERα) construct expressed on the surface of
Escherichia coli. These engineered bacterial sensors enable the
detection of many detrimental compounds as well as signal
amplification from impedance measurements as they bind to
modified electrodes. Rather than responding to individual
components, this approach reports the total estrogenic activity
of a sample using the biological receptor itself. Additional
features of this sensing strategy include sample volumes of only
10 μL, rapid response rates, and the use of low-cost, disposable
electrodes. As such, it is the first broad-spectrum EDC assay
that is appropriate for field use.
The current standards for EDC detection are cell-based
assays (originally the E-SCREEN assay14 and, more recently,
transactivation assays15,16 and yeast-based assays17,18) and
radioactive19 and fluorescent competition assays.20,21 The cell-
based transactivation involves the transcription of a reporter
gene, such as a luciferase gene, following the addition of the
compound in question. While effective, this analytical method is
problematic for rapid, point-of-care application, as it can require
multiple days of cell culture, specialized equipment, and trained
laboratory personnel. Similar problems arise with fluorescent
polarization assays, in which fluorescently labeled 17β-estradiol
is displaced from specific antibodies by estrogenic compounds.
This method requires several conjugation reactions and
optimization steps, and a specialized fluorometer is necessary
for measurement. As alternatives, efforts have been made to
develop rapid EDC detectors, including both fluorescent and
electrochemical sensors.2,22 While these platforms have had
success in detecting specific compounds or chemical families,
most are based on the binding of a single type of small
molecule to a particular antibody or DNA aptamer, precluding
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broad detection of estrogenic activity (EA). Furthermore,
antibodies can introduce cost and storage difficulties, and many
platforms require analyte labeling with an electrochemical
probe or fluorophore for detection.
The approach described herein is based on a novel
electrochemical sandwich assay (Figure 1a) and involves the
use of lyophilized E. coli to cause changes in the surface
impedance upon binding. Several unique aspects of this strategy
enable the detection of a range of estrogenic compounds at
exceptionally low concentrations. The E. coli surfaces are
engineered to display the ERα capture agent, which facilitates
detection of any compounds that associate with its binding
pocket.23 The use of lyophilized E. coli limits their viability and
increases storage life. The second component of the sandwich
assay is an electrochemical working electrode modified with a
previously reported protein that binds to ERα only when a
ligand is present.24,25 This protein is attached through the
interactions of a cysteine thiol with a disposable gold electrode
surface (Figure 1b). The specificity of the monobody is
observable by scanning electron microscopy of the working
electrode surfaces. In the presence of estradiol (E2), E. coli was
observed on the surface, while in the absence of E2, no E. coli
bound the surface (Figure 1c,d).
■ RESULTS AND DISCUSSION
The use of lyophilized E. coli as a scaffold for the ERα protein
resulted in significantly more sensitive measurements of E2
compared to the binding of ERα alone (Figure 2). The
Figure 1. Overview of the electrochemical sandwich assay. (a) Monobodies assembled on a gold electrode surface capture EDCs bound to estrogen
receptor α (ERα) that is surface expressed on E. coli. The binding of the large bacterial cells is easily detected by impedance spectroscopy. (b) The
device is constructed on disposable electrodes and requires a 10 μL sample volume. Scanning electron microscopy images are shown for the
monobody-modified gold electrode surface treated with lyophilized E. coli (c) in the absence of estradiol and (d) in the presence of 10 μM estradiol.
Scale bars represent 1 μm.
Figure 2. Electrochemical sandwich assay for endocrine disrupting compounds (EDCs). (a) Nyquist plots of estradiol detection with the platform at
concentrations ranging from 0 pM to 10 uM, along with the CPE fits used to determine the charge transfer radius (RCT). (b) Estradiol concentration
dependent RCT for ERα (blue), ERα on live E. coli (red), and ERα on lyophilized E. coli (black). Error bars represent the SD for n = 3 replicates.
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enhanced sensitivity is due to a substantially increased
impedance response from the recruitment of the large E. coli
cells to the gold surface, as compared to the significantly
smaller free protein (Figure 2b). Additionally, no signal change
is observed in the presence of E2 but with no E. coli or ERα
added (Figure S3). Both fresh and lyophilized E. coli were
tested, and a dependence on the number of cells used for
detection was observed (Figure S1). For lyophilized cells, the
optimal number of cells was found to be 104/mL. The number
of ERα proteins surface expressed on fresh E. coli was
determined to be approximately 70,000 using a fluorescent
coumarin−E2 conjugate,26 while on the lyophilized E. coli it
was slightly lower (50,000/cell) (Figure S2). This level of
surface expression is expected, as the maximum number of ice
Figure 3. Endocrine disrupting compound concentration dependent RCT for ERα on lyophilized E. coli with compounds that bind ERα: 4-
nonylphenol (4-NP, top left), genistein (GEN, top right), and diethylstilbestrol (DES, bottom left). Progesterone, which does not bind ERα, shows
no RCT response (bottom right). Error bars represent the SD for n = 3 replicates.
Figure 4. EDC detection from complex solutions. (a) Endocrine disrupting compound concentration dependent RCT for ERα on lyophilized E. coli
with BPA in buffer (turquoise) and in infant formula (purple). (b) Combinations of BPA, 4-NP, DES, and GEN with comparable estradiol
concentrations (black). Each solution contains 50% of one EDC, with 16.67% of each of the other three EDCs (where 100% would represent the
known IC50 concentration) . Samples with 50% BPA (dark blue), 50% 4-NP (turquoise), and 50% DES (green) are shown. (c) Estrogenicity of
plastic (red) and glass (blue) baby bottles before and after microwaving. Error bars represent the SD for n = 3 replicates.
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nucleation proteins that were fused to ERα is on the order of
100,000.27,28 Fresh E. coli resulted in a small impedance
response as compared to the lyophilized cells (Figure 2b) likely
due to their motility, which reduces their binding to the
electrode surface. This hypothesis was supported by comparing
detection with E. coli killed with sodium azide to E. coli
rendered nonviable, but alive and motile, by a low dose of
chloramphenicol. The chloramphenicol-treated E. coli behaved
as the untreated, live E. coli, and the sodium azide treated cells
behaved similarly to the lyophilized cells (Figure S3).
Consistent with this behavior, no E. coli from a live sample
were observed on electrodes by electron microscopy.
Detection of the binding event was accomplished with
electrochemical impedance spectroscopy (EIS) in ferricyanide/
ferrocyanide solution. This technique is rapid (providing
readout in minutes), sensitive, and label-free.29,30 Nyquist
plots were generated from each EIS scan performed, and the
data were fit to a constant phase element (CPE) circuit model
(Figure 2a). The charge transfer resistance (RCT) was derived
from the CPE fits and was found to be proportional to the
amount of ERα bound to the electrode and, therefore, the
amount of substrate present. Using RCT as a proxy for the
concentration of substrate, we were able to detect 500 pM E2
with a large linear range of detection up to 10 μM (Figure 2b).
As the required sample volume is especially low (10 μL), we
were able to detect femtomoles of estradiol at the detection
limit.
The system was found to be especially versatile, with
detection of chemicals that have disparate chemical structures
but similar bioactivity. The EDCs tested that bind ERα are 4-
nonylphenol (4-NP), genistein (GEN), diethylstilbestrol
(DES), and bisphenol A (BPA). Progesterone (P4) was used
as a negative control, as P4 is not a substrate for ERα binding.
In Figures 3 and 4a (turquoise), each EDC was tested over a
range of concentrations selected on the basis of their respective
IC50 values (shown as vertical lines). All agonists tested (4-NP,
GEN, DES, and BPA) produced linear responses over an
extended concentration range, with increasing RCT as EDC
concentration increased. Some nonlinearity was observed at
low concentrations of GEN, which could be due to complex-
ities in the ternary complex formation. For DES, reduced
linearity was observed as the detection limit was approached.
Each of these compounds was detectable at exceptionally low
concentrations, and most could be quantified below their IC50
values. DES was detectable to concentrations ten times its IC50
value. Unlike the EDCs that bind ERα, this platform shows no
response to progesterone, indicating its specificity for estro-
genic compounds. Similarly, this platform showed no response
to the antagonist tamoxifen (TAM), indicating that the
conformation of the ERα−antagonist complex does not bind
the monobody on the electrode surface (Figure S5).
In contaminated systems, EDCs rarely occur as a single
compound. Rather, they are often mixed, providing an
aggregate effect. The combined interaction of all the EDCs
present with the ERα protein yields a response that can be
benchmarked as a concentration of the native substrate, E2,
that would produce similar activity. This equivalent response is
termed the “estrogenic activity” (EA) of the solution. The
sensor was therefore evaluated for its ability to determine EA of
complex mixtures. The EDCs previously measured (BPA, 4-
NP, DES, and GEN) were combined and compared with
comparable estradiol concentrations. Each solution contained
50% of one EDC (relative to its IC50 value), with 16.67% of
each of the other three EDCs. The absolute concentrations of
the components appear in Table S1. The RCT values for the
combined EDCs were compared to the equivalent concen-
tration of E2 as a measure of the EA of the solution.
Independent of the ratio of EDCs in the solution, the RCT was
found to be comparable to the equivalent concentration of E2
(Figure 4b). This platform therefore shows the distinct
advantage of providing a readout of the total EA from a
complex mixture of components even when their specific
identities are unknown.
Importantly, this approach enables detection of target
compounds present in complex mixtures of proteins and
small molecules. As EDCs are especially deleterious for proper
development, their presence has been especially problematic in
infant products. As one relevant example, the detection of BPA
was evaluated in infant formula (Figure 4a). BPA was added to
reconstituted formula from a commercial source in varying
concentrations. The ability of the system to detect BPA was
linear above the IC50 value, despite the addition of protein,
lipid, and small molecule components. Below this concen-
tration, the signal was indistinguishable from background, likely
due to surface passivation from proteins in the formula.
As a final experiment, we evaluated the ability of the system
to detect EA from an everyday source without prior knowledge
of the contaminants. In the literature, E-SCREEN assays have
shown that certain “BPA-free” plastic baby bottles release EDCs
upon microwave heating.31 We sought to replicate this
experiment using the faster and lower volume electrochemical
assay described herein. Prior to microwave heating the plastic
bottle, the buffer had no observable EA. However, after
microwaving for ten 2 min periods, the buffer in the plastic
bottle had significant EA, comparable to 100 nM E2. In
contrast, the buffer in a glass bottle contained no EA before or
after microwaving (Figure 4c).
Through this work, we have developed a new approach for
determining the estrogenic activity of endocrine disrupting
compounds. By combining impedance spectroscopy based
detection with the signal amplification provided by a lyophilized
E. coli scaffold, large responses in the charge transfer resistance
of the electrode are observed, even in the presence of sub-ppb
estradiol. The system provides the first reported sensor that
responds broadly to all EDCs, and since it is based on
inexpensive disposable electrode technology, it can be used in
the field. The 10 μL sample size is far smaller than that needed
for cell-based growth assays, and the readout is available in
minutes, not days. Furthermore, the application of lyophilized
E. coli as a scaffold for our protein provides a new method of
signal amplification, and is crucially important for reaching the
low detection limits that these compounds require. The system
also shows promising compatibility with complex sample
matrices, such as infant formula. This new sensing approach
should be applicable to other diverse families of compounds
that bind to a single receptor, such as PPARγ, and current
efforts in our laboratory are exploring these possibilities.
■ METHODS
Plasmid Preparation. Monobody Encoding pSKB3
Vector. The gene encoding for the ERα-estradiol selective
monobody protein, a sequence adapted from Koide et al.,19,20
was synthesized by IDT Technologies with BamHI and XhoI
restriction sites at the 5′- and 3′-ends and subcloned into a
pSKB3 vectora variation of Novagen’s pET-28a vector with
the thrombin site exchanged for a TEV proteolysis site. The
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insert and vector backbone were double digested (BamHI/
XhoI), heat inactivated at 80 °C for 5 min, ligated with
QuickLigase (NEB) at a 5:1 molar ratio, and transformed into
XL1Blue competent cells. Plating on kanamycin agar plates
yielded individual colonies, which were cultured, DNA purified
(NucleoSpin, MacheryNagel), and sequenced (Quintara
BioSciences).
INPNC-ERα Encoding pSKB3 Vector. The synthetic gene
(IDT Technologies) of ERα (organism, Homo sapiens; gene,
ESR1, accession number P03372; residue number, 301−552)
was subcloned with NheI and NotI restriction sites at the 5′-
and 3′-ends into a pSKB3 vector containing an N-terminal
maltose binding protein (MBP). The resulting vector furnished
the following amino acid sequence: MASS-(His)6-TEV-MBP-
Linker-ERα (where “Linker” = N10-LGASGSG).
The gene insert coding for the ice nucleation protein with
the NC-terminal fusion (INPNC: fusion of the N-terminal
membrane domain INPN and the C-terminal extracellular
domain INPC) was synthesized by IDT Technologies with
Nco1 and Nhe1 restriction sites at the 5′- and 3′-sites and was
subcloned into the MBP-ERα pSKB3 vector above. The MBP
gene was removed in the process. The resulting vector encodes
for the following amino acid sequence: MAA-INPN-RS-INPC-
SSN10LGASGSG-ERα. The INPNC insert and vector back-
bone were double digested (NcoI/NheI), heat inactivated at 65
°C for 15 min, ligated with QuickLigase (NEB) at a 5:1 molar
ratio, and transformed into XL1Blue competent cells. Plating
on kanamycin agar plates yielded individual colonies, which
were cultured, DNA purified (NucleoSpin, MacheryNagel), and
sequenced (Quintara BioSciences).
Protein Expression and Purification. Plasmids were
transformed into E. coli BL21 (DE3) competent cells. Starter
cultures (20 mL of LB, 50 mg/L kanamycin) were grown from
single colonies overnight at 37 °C and used to inoculate 1 L of
TB medium (50 mg/L kanamycin). Cultures were grown to an
OD ∼ 0.5, cooled to 25 °C for 20 min, induced with 0.5 mM
IPTG, and expressed overnight (18 h) at 25 °C. Cells were
harvested by centrifugation for 15 min at 4000 rcf at 4 °C. The
protein was purified directly without freezing.
Purification of Monobody Protein. The pellet was trans-
ferred to PBS buffer and centrifuged for 10 min at 4300 rcf. The
resulting pellet was lysed in 30 mL of lysis buffer, referred to
hereafter as buffer B (20 mM bicine, pH 8.5, 500 mM NaCl, 10
mM imidazole), supplemented with one tablet of EDTA-free
SigmaFast Protease Inhibitor (Sigma-Aldrich), 5 mM PMSF,
and 2 mg of lysozyme. Without incubation, the resuspension
was lysed with an Avestin C3 homogenizer followed by a 20
min centrifugation at 24,000 rcf at 4 °C. The supernatant was
filtered through a 40 μm Steriflip filter (Millipore) and loaded
onto a 5 mL NiNTA column (Protino, Machery Nagel)
connected to an Akta purifier preequilibrated with buffer B.
The column was washed with 50 mL (10 column volumes) of
20 mM bicine (pH 8.5), 500 mM NaCl, 10 mM imidazole, 10
mM β-ME. The protein was eluted with 20 mM bicine (pH
8.5), 500 mM NaCl, 250 mM imidazole, 10 mM β-Me.
Imidazole was removed by exchanging against 20 mM bicine
(pH 8.5), 500 mM NaCl, with a 10DG desalting column
(BioRad). For purposes of lyophilization, the protein was
directly exchanged against 20 mM bicine (pH 8.5) and 100 mM
trehalose, followed by flash freezing with liquid N2 and
lyophilization (Labconco) overnight. Typical protein yields
are 800 μM (3 mL total) from a 1 L culture, with a purity of
∼98% by SDS−PAGE and LC−MS (ESI-TOF) (6224 TOF
and 1200 series HPLC, Agilent Technologies).
Expression of Cell Surface Displayed INPNC-ERα. INPNC-
ERα was expressed from single BL21 colonies. The proteins
were grown in 50 mL of TB in the presence of 50 mg/L
kanamycin. At an OD600 ∼ 0.5 the culture was equilibrated to
25 °C for 20 min, induced with 0.5 mM IPTG, and expressed
overnight (18 h) at 25 °C. The cells were centrifuged for 5 min
at 4000 rcf and resuspended either in M9 minimal medium for
direct use or in 20 mM HEPES (pH 7.5) with 100 mM
trehalose for lyophilization. E. coli cells were lyophilized by flash
freezing 100 μL aliquots in liquid nitrogen at an OD600 ∼ 0.1.
The lyophilized samples were stored at either −20 °C or −80
°C. Sodium azide (NaN3) treated cells were incubated with 5
mg/mL NaN3 to induce toxicity. Chloramphenicol-treated cells
were incubated with 10 μg/mL of chloramphenicol for 30 min,
a concentration below toxicity but sufficient to inhibit protein
synthesis.
Cell Viability of Lyophilized E. coli Cultures. The
lyophilized sample produced from 100 μL at OD600 = 0.1 was
dissolved in 600 μL of M9 minimal medium, and 125 μL
volumes were streaked onto kanamycin agar plates. No colonies
were observed after 24 h; colonies observed after 48 h were
counted and compared against equivalently plated cells streaked
from glycerol stocks.
Reconstitution of E. coli Cells. Aliquots of E. coli were
reconstituted by dissolution in 100 μL of 20 mM HEPES (pH
7.5) to an OD of 0.1. Cells were incubated on ice for 20 min
prior to further dilution.
Determination of Surface-Expressed ERα. An estradiol−
coumarin conjugate (prepared as described in ref 21) was
added to a final concentration of 10 μM to either freshly
harvested or lyophilized E. coli at an OD600 of 0.01 in M9
medium. Following a 20 min incubation, cells were purified
from unbound E2−coumarin by spin filtration (10K; 5 min,
5000 rcf). The fluorescence of the E2−coumarin labeled cells
was measured and compared to a standard curve of estradiol−
coumarin fluorescence in M9 medium. Using the concentration
of estradiol−coumarin, the number of receptors per E. coli cell
was estimated.
Electrode Preparation. Disposable gold electrodes (1.3
mm diameter, cold annealed, DropSens) were preliminarily
prepared in 0.5 M H2SO4 by scanning from 1.3 V to −0.2 V (vs
internal reference, 100 mV scan rate, 9 scans). Electrodes were
subsequently washed with Milli-Q water. Lyophilized mono-
body was diluted in 20 mM HEPES, 300 mM NaCl (pH 7.5) to
a final concentration of 50 μM. A 10 μL portion was added to
the electrode surface. Electrodes were placed in humidifier
boxes and incubated overnight at 4 °C. Prior to detection using
the monobody-modified electrodes, the electrodes were rinsed
with 3 aliquots of 100 μL of 20 mM HEPES (pH 7.5).
Incubation of Analytes. Following reconstitution of
lyophilized E. coli samples, the cells were diluted to the desired
final concentration (104 cells/mL, although cells were tested at
concentrations ranging from 103 to 107) in 20 mM HEPES (pH
7.5). For the detection of single endocrine disrupting chemicals
(estradiol, DES, GEN, BPA, or 4-NP), the chemical was
dissolved in DMSO to a 1000× dilution of the final
concentration, such that the concentration of DMSO was
constant at 0.1% v/v in solution with E. coli, including negative
controls (in which either no cells or no EDC was added).
The EDC of interest was incubated with the E. coli for 20
min in solution prior to application to the electrode. A 10 μL
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portion of the E. coli solution containing the analyte
compounds was then added to the electrode surface. E. coli
solutions were incubated on the electrode surface for 20 min at
ambient temperature in a humidifier box. The electrodes were
subsequently rinsed with 3 aliquots of 100 μL of 20 mM
HEPES (pH 7.5).
Electrochemical Impedance Spectroscopy. Electrochemical
impedance spectroscopy (EIS) was performed with a Gamry
Reference 600 potentiostat. The buffer consisted of 4 mM each
of K3Fe(CN)6/K4Fe(CN)6 in 0.1 M KCl. Electrochemical
measurements were acquired at the open circuit potential of the
electrode and measured for 60 s prior to EIS. EIS measure-
ments were made from 50,000 to 0.2 Hz with 10 points per
decade and a 10 mV ac voltage. Electrochemical data analysis,
including circuit modeling, was performed using the Gamry
Echem Analyst software. Charge transfer resistance (RCT) was
derived from a constant phase element (CPE) with diffusion
circuit model fit.
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